Fengjun Sun
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
- Endocrinology top 5%
- Vibrio bacteria research studies
Papers in
-
- Antibiotic Resistance in Bacteria 25
-
- Antifungal resistance and susceptibility 7
- Antimicrobial Resistance in Staphylococcus 6
- Co-authors
- Peiyuan Xia (44 shared papers)Wei Feng (20 shared papers)Dongsheng Zhou (12 shared papers)Jing Ouyang (6 shared papers)Xuewen Qiu (10 shared papers)Wei Feng (18 shared papers)Yixuan Sun (4 shared papers)Peiyuan Xia (13 shared papers)
- Journals
- Frontiers in Microbiology (5 papers)Frontiers in Pharmacology (4 papers)Journal of Chemotherapy (4 papers)Microbial Pathogenesis (4 papers)Scientific Reports (3 papers)
- Partner nations
- ChinaSouth KoreaUnited Kingdom
In The Last Decade
Fengjun Sun
105 papers receiving 2.5k citations
Fengjun Sun's Hit Papers
Peers
Comparison fields: 5 of 105
- Molecular Medicine 433
- Endocrinology 105
- Drug Discovery 7
- Biomaterials 147
- Applied Microbiology and Biotechnology 27
Countries citing papers authored by Fengjun Sun
This map shows the geographic impact of Fengjun Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengjun Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengjun Sun more than expected).
Fields of papers citing papers by Fengjun Sun
This network shows the impact of papers produced by Fengjun Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengjun Sun. The network helps show where Fengjun Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengjun Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 247 | |
| 2 | 2013 | 179 | |
| 3 | Global, regional, and national burden and trends of migraine among women of childbearing age from 1990 to 2021: insights from the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 126 |
| 4 | 2019 | 124 | |
| 5 | 2010 | 89 | |
| 6 | 2011 | 70 | |
| 7 | 2020 | 67 | |
| 8 | 2014 | 59 | |
| 9 | 2016 | 53 | |
| 10 | 2012 | 52 | |
| 11 | 2016 | 50 | |
| 12 | 2019 | 50 | |
| 13 | 2014 | 49 | |
| 14 | 2015 | 48 | |
| 15 | 2020 | 45 | |
| 16 | 2017 | 40 | |
| 17 | 2012 | 39 | |
| 18 | 2012 | 38 | |
| 19 | 2021 | 38 | |
| 20 | 2022 | 36 |
About Fengjun Sun
Fengjun Sun is a scholar working on Molecular Medicine, Infectious Diseases, Endocrinology, Complementary and alternative medicine and Pharmacology, having authored 109 papers that have together received 2.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (25 papers), Bacterial biofilms and quorum sensing (16 papers), Antifungal resistance and susceptibility (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Pharmacogenetics and Drug Metabolism (5 papers), Urinary Tract Infections Management (5 papers) and Natural Compounds in Disease Treatment (3 papers). The work is most often cited by research in Molecular Medicine (433 citations), Endocrinology (105 citations), Drug Discovery (7 citations), Biomaterials (147 citations) and Applied Microbiology and Biotechnology (27 citations). Fengjun Sun has collaborated with scholars based in China, South Korea and United Kingdom. Frequent co-authors include Peiyuan Xia, Wei Feng, Dongsheng Zhou, Jing Ouyang, Xuewen Qiu, Wei Feng, Yixuan Sun, Peiyuan Xia, Lize Xiong and Y. Chen. Their work appears in journals such as Frontiers in Microbiology, Frontiers in Pharmacology, Journal of Chemotherapy, Microbial Pathogenesis and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.